Franklin Resources Inc Beam Therapeutics Inc. Transaction History

Franklin Resources Inc

$378 Billion
Q3 2025

A detailed history of Franklin Resources Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 21,382 shares of BEAM stock, worth $470,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,382

Previous 19,098 11.96%

Holding current value

$470,831

Previous $324,000 59.88%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$16.01 - $25.1 $36,566 - $57,328	2,284 Added 11.96%	21,382 $518,000
Q2 2025 Aug 12, 2025	SELL	$14.54 - $20.24 $21,446 - $29,853	-1,475 Reduced 7.17%	19,098 $324,000
Q1 2025 May 13, 2025	SELL	$19.53 - $34.09 $15,233 - $26,590	-780 Reduced 3.65%	20,573 $401,000
Q4 2024 Feb 12, 2025	BUY	$21.55 - $30.35 $136,088 - $191,660	6,315 Added 41.99%	21,353 $529,000
Q3 2024 Nov 12, 2024	BUY	$22.57 - $33.14 $339,407 - $498,359	15,038 New	15,038 $368,000

Q2 2022 Aug 11, 2022	SELL	$29.86 - $62.36 $151,748 - $316,913	-5,082 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$53.73 - $82.16 $102,516 - $156,761	-1,908 Reduced 27.3%	5,082 $291,000
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $12,447 - $18,127	183 Added 2.69%	6,990 $557,000
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $288,292 - $456,511	3,417 Added 100.8%	6,807 $593,000
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $52,450 - $105,284	818 Added 31.8%	3,390 $436,000
Q1 2021 May 13, 2021	BUY	$71.28 - $120.75 $183,332 - $310,569	2,572 New	2,572 $206,000
Q2 2020 Aug 13, 2020	SELL	$15.26 - $28.66 $4.59 Million - $8.61 Million	-300,509 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$13.31 - $29.2 $4 Million - $8.77 Million	300,509 New	300,509 $5.41 Million

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Beam Therapeutics Inc. Transaction History